Xuemei Luo

4.5k total citations · 1 hit paper
112 papers, 3.3k citations indexed

About

Xuemei Luo is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics. According to data from OpenAlex, Xuemei Luo has authored 112 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Cardiology and Cardiovascular Medicine, 32 papers in Internal Medicine and 17 papers in Economics and Econometrics. Recurrent topics in Xuemei Luo's work include Atrial Fibrillation Management and Outcomes (45 papers), Venous Thromboembolism Diagnosis and Management (32 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). Xuemei Luo is often cited by papers focused on Atrial Fibrillation Management and Outcomes (45 papers), Venous Thromboembolism Diagnosis and Management (32 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). Xuemei Luo collaborates with scholars based in United States, United Kingdom and China. Xuemei Luo's co-authors include Lloyd A. Hey, Ricardo Pietrobon, Shawn X. Sun, Gordon G. Liu, Karen S. Frush, Jack Mardekian, Allison Keshishian, Xianying Pan, William J. Richardson and Gregory Y.H. Lip and has published in prestigious journals such as Circulation, Blood and Gastroenterology.

In The Last Decade

Xuemei Luo

110 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimates and Patterns of Direct Health Care Expenditures Among Individuals With Back Pain in the United States

2003 645 citations Xuemei Luo, Lloyd A. Hey et al. profile →

Peers

Countries citing papers authored by Xuemei Luo

Since Specialization

Citations

This map shows the geographic impact of Xuemei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuemei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuemei Luo more than expected).

Fields of papers citing papers by Xuemei Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuemei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuemei Luo. The network helps show where Xuemei Luo may publish in the future.

Co-authorship network of co-authors of Xuemei Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xuemei Luo. A scholar is included among the top collaborators of Xuemei Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuemei Luo. Xuemei Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness and Safety of Extended Treatment Apixaban Versus Low-Molecular-Weight Heparin in Cancer-Associated Venous Thromboembolism 2024 ·Journal of the National Comprehensive Cancer Network ·Alexander T. Cohen, Amol D. Dhamane, Xuejun Liu, (unknown), Stella Han, (unknown), Jane Wang, Xuemei Luo	1
2	Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims 2024 ·Journal of Thrombosis and Thrombolysis ·Gregory Y.H. Lip, (unknown), Amiee Kang, Xuemei Luo, (unknown), Stella Han, (unknown), Jenny Jiang, (unknown), Steven Deitelzweig	1
3	Mid‐dosing interval concentration is important for polymyxin B exposure and acute kidney injury in critically ill patients 2023 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), (unknown), Siqi Huang, Min Wang, (unknown), Xuemei Luo, Qi Chen, Na Yang, Huaijun Zhu	2
4	Analysis of Factors Influencing Whole Blood Hydroxychloroquine Concentration in Patients with Systemic Lupus Erythematosus in China 2023 ·Rheumatology and Therapy ·Xuan Huang, Qing Shu, Xuemei Luo, Weihong Ge, (unknown), Yujie Zhou	2
5	Clinical outcomes and treatment patterns among Medicare patients with nonvalvular atrial fibrillation (NVAF) and chronic kidney disease 2019 ·PLoS ONE ·Lauren E. Wilson, Xuemei Luo, Xiaoyan Li, Jack Mardekian, Alessandra Bassalobre García, Asheley Cockrell Skinner	8
6	EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS 2019 ·Journal of the American College of Cardiology ·Steven Deitelzweig, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Xiaoyan Li, (unknown), Lisa Rosenblatt, Jack Mardekian, Xianying Pan, Manuela Di Fusco, Alessandra Bassalobre García, Hüseyin Yüce, Gregory Y.H. Lip	1
7	Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure 2019 ·PLoS ONE ·Alpesh Amin, Alessandra Bassalobre García, Xiaoyan Li, Amol D. Dhamane, Xuemei Luo, Manuela Di Fusco, Anagha Nadkarni, Keith Friend, Lisa Rosenblatt, Jack Mardekian, Xianying Pan, Hüseyin Yüce, Allison Keshishian	22
8	COMPARISON OF EFFECTIVENESS, SAFETY, AND THE NET CLINICAL OUTCOME BETWEEN DIFFERENT DIRECT ORAL ANTICOAGULANTS IN 162,707 NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED IN US CLINICAL PRACTICE 2018 ·Journal of the American College of Cardiology ·Steve Deitelzweig, Allison Keshishian, Xiaoyan Li, Melissa Hamilton, Cristina Masseria, Kiran Gupta, Xuemei Luo, Jack Mardekian, Keith Friend, Anagha Nadkarni, Xianying Pan, Onur Başer, Gregory Y.H. Lip	3
9	Abstract 16462: Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Among Non-Valvular Atrial Fibrillation Patients: A Propensity Score Matched Analysis of Four Large Databases 2017 ·Circulation ·Steve Deitelzweig, Allison Keshishian, Xiaoyan Li, Melissa Hamilton, Cristina Masseria, Kiran Gupta, Xuemei Luo, Jack Mardekian, Keith Friend, Anagha Nadkarni, Xianying Pan, Gregory Y.H. Lip	1
10	REAL WORLD EVALUATION OF MAJOR BLEEDING RISK AND COSTS FOR ALL CAUSES AND BLEEDING-RELATED HEALTH SERVICES AMONG ELDERLY PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION TREATED WITH APIXABAN OR WARFARIN 2017 ·Journal of the American College of Cardiology ·Steven Deitelzweig, Xuemei Luo, Kiran Gupta, Jeffrey Trocio, Jack Mardekian, (unknown), Melissa Lingohr-Smith, (unknown), Jay Lin	1
11	Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice 2017 ·Thrombosis and Haemostasis ·Xiaoyan Li, Steve Deitelzweig, Allison Keshishian, Melissa Hamilton, Ruslan Horblyuk, Kiran Gupta, Xuemei Luo, Jack Mardekian, Keith Friend, Anagha Nadkarni, Xianying Pan, Gregory Y.H. Lip	122
12	Abstract 17298: Real-world Evaluation of Healthcare Resource Use and Costs of Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Apixaban vs. Warfarin in the US 2016 ·Circulation ·Steve Deitelzweig, Xuemei Luo, Kiran Gupta, Jeffrey Trocio, Jack Mardekian, Melissa Lingohr-Smith, (unknown), Jay Lin	1
13	Hormone replacement therapy use in UK general practice: Duration, discontinuation and women’s experience 2016 ·Post Reproductive Health ·Pippa Anderson, (unknown), Margaret A. J. Moffat, Xuemei Luo	2
14	The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe 2015 ·Journal of Women s Health ·Marco DiBonaventura, Xuemei Luo, (unknown), Andrew G. Bushmakin, (unknown), Joel Bobula	87
15	Bazedoxifene versus Oral Bisphosphonates for the Prevention of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis at Higher Risk of Fracture: A Network Meta-Analysis 2014 ·Value in Health ·Alexandra G. Ellis, Jean‐Yves Reginster, Xuemei Luo, Joseph C. Cappelleri, Arkadi Chines, Santosh Sutradhar, Jeroen P. Jansen	27
16	Impact of upper and lower gastrointestinal blood loss on healthcare utilization and costs: a systematic review 2011 ·Journal of Medical Economics ·Donna R. Parker, Xuemei Luo, Jessica J. Jalbert, Annlouise R. Assaf	34
17	Health Utilities Associated with Hemoglobin Levels and Blood Loss in Postmenopausal Women: The Women's Health Initiative 2011 ·Value in Health ·B. Harrow, Charles B. Eaton, Mary B. Roberts, Annlouise R. Assaf, Xuemei Luo, (unknown)	6
18	Enhancing Pediatric Safety: Using Simulation to Assess Radiology Resident Preparedness for Anaphylaxis from Intravenous Contrast Media 2007 ·Radiology ·A Gaca, Donald P. Frush, Susan M. Hohenhaus, Xuemei Luo, (unknown), (unknown), Karen S. Frush	48
19	Relationships of Clinical, Psychologic, and Individual Factors with the Functional Status of Neck Pain Patients 2004 ·Value in Health ·Xuemei Luo, Christopher L. Edwards, William J. Richardson, Lloyd A. Hey	49
20	Effect of an Intervention Standardization System on Pediatric Dosing and Equipment Size Determination 2003 ·Archives of Pediatrics and Adolescent Medicine ·(unknown), Karen S. Frush, Xuemei Luo, Robert L. Wears	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact